About the company
OEP Philippines, the largest subsidiary in terms of sales revenue of Orient Europharma Taiwan, is focused on marketing prescription medicines of a wide range of therapeutic classes, including anti-hypertensives, anti-anginals, anti-infectives and products for the treatment of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and allergic rhinitis.
OEP Philippines currently ranks number 26 among all ethical pharmaceutical corporations in the Philippines. The company is in its third consecutive year of double digit growth which is well above the industry average. Our growth is based on our commitment to serve the community by providing medicine that works (new or established) at fair prices.